DEJA DAVIS: Open Payments
NPI 1205465986 · SUFFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,545 in 54 payments from 11 companies in 2025. Trend: 2023 $6,677 · 2024 $6,713 · 2025 $6,545
Speaker / faculty: $5,563Food & beverage: $744Travel & lodging: $239
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $6,039 |
| Biogen, Inc. | 12 | $165 |
| PFIZER INC. | 2 | $62 |
| Lundbeck LLC | 2 | $49 |
| Neurocrine BioSciences, Inc. | 2 | $44 |
| Mallinckrodt Hospital Products Inc. | 1 | $34 |
| Celgene Corporation | 2 | $34 |
| UCB, Inc. | 1 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| Genentech USA, Inc. | 1 | $31 |
Products named: QULIPTA, VUMERITY, UBRELVY, NURTEC ODT, VYEPTI, INGREZZA, ACTHAR, ZEPOSIA.
Industry payments across VA — which companies pay providers there.
